Wholesale of pharmaceutical and medical goods
FYSIOLINE NORWAY AS
Revenue 2025
NOK 5.7m
Operating profit
NOK −675,000
Equity
NOK −6.9m
Incorporated
2022
Share capital
NOK 30,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2025 | Trend |
|---|---|---|
| Total operating revenue | 5.7m | |
| Total operating costs | 6.4m | |
| Operating profit (EBIT) | −675k | |
| Net financial items | −46k | |
| Profit for the year | −722k |
Balance sheet
| Post | 2025 | Trend |
|---|---|---|
| Total assets | 2.7m | |
| of which current assets | 2.6m | |
| Equity | −6.9m | |
| Total liabilities | 9.6m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.